Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26024214 | 0.82 | HSD17B10 (0.33) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL16224559 | 0.79 | USP2 (0.39) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL2395205 | 0.79 | USP2 (0.39) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL24918232 | 0.79 | USP2 (0.39) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL22820950 | 0.78 | NPC1 (0.38) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL24694360 | 0.77 | USP30 (0.33) | USP2SMN1; SMN2NR1H2HSD17B10 | |
| SCHEMBL31708282 | 0.75 | ALDH1A1 (0.36) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL27117596 | 0.75 | USP2 (0.36) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL4561006 | 0.75 | NPC1 (0.36) | USP2SMN1; SMN2NR1H2HSD17B10CHRM2 | |
| SCHEMBL4766170 | 0.73 | HSD17B10 (0.42) | HSD17B10CHRM2CHRM1CHRM3HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020257549-A2 | COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES | CHEMOCENTRYX, INC. (US) | 2020-12-24 | — | — | WO | disclosed |